C

Cocrystal Pharma
D

COCP

1.96000
USD
-0.04
(-2.00%)
مغلق
حجم التداول
1
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
19,940,628
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Cocrystal Pharma

القطاع: Healthcare
الصناعة: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).